63 related articles for article (PubMed ID: 15887854)
1. Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution.
Dom G; Frank S; Floor S; Kehagias P; Libert F; Hoang C; Andry G; Spinette A; Craciun L; de Saint Aubin N; Tresallet C; Tissier F; Savagner F; Majjaj S; Gutierrez-Roelens I; Marbaix E; Dumont JE; Maenhaut C
Oncotarget; 2018 Feb; 9(12):10343-10359. PubMed ID: 29535811
[TBL] [Abstract][Full Text] [Related]
2. Challenge in the Pathological Diagnosis of the Follicular- Patterned Thyroid Lesions.
Elsers DA; Hussein MRA; Osman MH; Mohamed GA; Hosny G
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3365-3376. PubMed ID: 34711014
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 Performance in Histologic a Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis.
Trimboli P; Virili C; Romanelli F; Crescenzi A; Giovanella L
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800068
[TBL] [Abstract][Full Text] [Related]
4. Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.
Duquette M; Sadow PM; Husain A; Sims JN; Antonello ZA; Fischer AH; Song C; Castellanos-Rizaldos E; Makrigiorgos GM; Kurebayashi J; Nose V; Van Hummelen P; Bronson RT; Vinco M; Giordano TJ; Dias-Santagata D; Pandolfi PP; Nucera C
Oncotarget; 2015 Dec; 6(40):42445-67. PubMed ID: 26636651
[TBL] [Abstract][Full Text] [Related]
5. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.
Dunđerović D; Lipkovski JM; Boričic I; Soldatović I; Božic V; Cvejić D; Tatić S
Diagn Pathol; 2015 Oct; 10():196. PubMed ID: 26503236
[TBL] [Abstract][Full Text] [Related]
6. Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E).
Husain A; Hu N; Sadow PM; Nucera C
Cancer Lett; 2016 Oct; 380(2):577-585. PubMed ID: 26189429
[TBL] [Abstract][Full Text] [Related]
7. Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis.
de Matos LL; Del Giglio AB; Matsubayashi CO; de Lima Farah M; Del Giglio A; da Silva Pinhal MA
Diagn Pathol; 2012 Aug; 7():97. PubMed ID: 22888980
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of galectin-3 in thyroid cancer.
Chiu CG; Strugnell SS; Griffith OL; Jones SJ; Gown AM; Walker B; Nabi IR; Wiseman SM
Am J Pathol; 2010 May; 176(5):2067-81. PubMed ID: 20363921
[TBL] [Abstract][Full Text] [Related]
9. Increasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markers.
Fontaine JF; Mirebeau-Prunier D; Raharijaona M; Franc B; Triau S; Rodien P; Goëau-Brissonniére O; Karayan-Tapon L; Mello M; Houlgatte R; Malthiery Y; Savagner F
PLoS One; 2009 Oct; 4(10):e7632. PubMed ID: 19893615
[TBL] [Abstract][Full Text] [Related]
10. What is New on Thyroid Cancer Biomarkers.
Ruggeri RM; Campennì A; Baldari S; Trimarchi F; Trovato M
Biomark Insights; 2008 Apr; 3():237-252. PubMed ID: 19578508
[TBL] [Abstract][Full Text] [Related]
11. The investigation of galectin-3 in diseases of the thyroid gland.
Kovács RB; Földes J; Winkler G; Bodó M; Sápi Z
Eur J Endocrinol; 2003 Nov; 149(5):449-53. PubMed ID: 14585093
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
13. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
[TBL] [Abstract][Full Text] [Related]
14. [Thyroid Adenomas in Children].
Morozov DA; Pimenova ES; Mirokova ED
Vestn Ross Akad Med Nauk; 2015; (5):513-8. PubMed ID: 26846075
[TBL] [Abstract][Full Text] [Related]
15. Human galectin-3 immunoexpression in thyroid follicular adenomas with cell atypia.
Nucera C; Mazzon E; Caillou B; Violi MA; Moleti M; Priolo C; Sturniolo G; Puzzolo D; Cavallari V; Trimarchi F; Vermiglio F
J Endocrinol Invest; 2005 Feb; 28(2):106-12. PubMed ID: 15887854
[TBL] [Abstract][Full Text] [Related]
16. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]